Submit your paper
  • French
  • English
Home All issues Volume 21/ 1 Article
Open Access
Issue Ann Toxicol Anal
Volume 21, Number 1, 2009
Page(s) 3 - 8
DOI http://dx.doi.org/10.1051/ata/2009030
Published online 30 April 2009

References of  Ann Toxicol Anal. 2009; 21(1): 3-8
  1. Pil K, Verstraete A. Current developments in drug testing in oral fluid. Ther Drug Monit. 2008; 30(2): 196-202 [CrossRef] [PubMed].
  2. Verstraete AG. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int. 2005; 150(2-3): 143-150 [CrossRef] [PubMed].
  3. Drummer OH. Urine and oral fluid in workplace drug testing. TIAFT Bulletin 2008; 38(2): 39-40.
  4. Rodgers R, Lee RH, Allen MP. Detection of cannabis in saliva using a test strip immunoassay. 1984; Proceedings of the TIAFT meeting in Brighton: 215.
  5. Moore C, Coulter C, Rana S, Vincent M, Soares J. Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. J Anal Toxicol. 2006; 30(7): 409-412 [PubMed].
  6. Moore C et coll. Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays. J Anal Toxicol. 2006; 30(7): 413-418 [PubMed].
  7. Kintz P, Cirimele V, Ludes B. Codeine testing in sweat and saliva with the Drugwipe. Int J Legal Med. 1998; 111(2): 82-84 [CrossRef] [PubMed].
  8. Mura P, Kintz P, Papet Y, Ruesch G, Piriou A. Evaluation of six rapid tests for screening of cannabis in sweat, saliva and tears. Acta Clin Belg Suppl. 1999; 1: 35-38 [PubMed].
  9. Jehanli A, Brannan S, Moore L, Spiehler VR. Blind trials of an onsite saliva drug test for marijuana and opiates. J Forensic Sci. 2001; 46(5): 1214-1220 [PubMed].
  10. Crouch DJ. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci Int. 2005; 150(2-3): 165-173 [CrossRef] [PubMed].
  11. O'Neal CL, Crouch DJ, Rollins DE, Fatah AA. The effects of collection methods on oral fluid codeine concentrations. J Anal Toxicol. 2000; 24(7): 536-542 [PubMed].
  12. Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P. Drug testing in oral fluid-evaluation of sample collection devices. J Anal Toxicol. 2008; 32(6): 393-401 [PubMed].
  13. Drummer OH, Gerostamoulos D, Chu M, Swann P, Boorman M, Cairns I. Drugs in oral fluid in randomly selected drivers. Forensic Sci Int. 2007; 170(2-3): 105-110 [CrossRef] [PubMed].
  14. Chu MH, Drummer OH. Determination of delta 9-THC in whole blood using gas chromatography-mass spectrometry. J Anal Toxicol. 2002; 26(8): 575-581 [PubMed].
  15. Verstraete AG, Raes E. Rosita-2 project. Final report. Gent : Academia Press, 2006.
  16. Cirimele V, Villain M, Mura P, Bernard M, Kintz P. Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS. Forensic Sci Int. 2006; 161(2-3): 180-184 [CrossRef] [PubMed].
  17. Crouch DJ, Walsh JM, Cangianelli L, Quintela O. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices. Ther Drug Monit. 2008; 30(2): 188-195 [CrossRef] [PubMed].
  18. Crouch DJ, Walsh JM, Flegel R, Cangianelli L, Baudys J, Atkins R. An evaluation of selected oral fluid point-of-collection drug-testing devices. J Anal Toxicol. 2005; 29(4): 244-248 [PubMed].
  19. De Giovanni N, Fucci N, Chiarotti M, Scarlata S. Cozart Rapiscan system: our experience with saliva tests. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 773(1): 1-6 [CrossRef] [PubMed].
  20. Iwersen S, Schmoldt A. Frontline test sticks for drug testing in saliva? TIAFT proceeedings of the TIAFT meeting in Munich, 1996.
  21. Kintz P, Bernhard W, Villain M, Gasser M, Aebi B, Cirimele V. Detection of cannabis use in drivers with the Drugwipe device and by GC-MS after Intercept device collection. J Anal Toxicol. 2005; 29(7): 724-727 [PubMed].
  22. Kintz P, Cirimele V, Ludes B. Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers. J Anal Toxicol. 2000; 24(7): 557-561 [PubMed].
  23. Kintz P, Cirimele V, Mairot F, Muhlmann M, Ludes B. Drug tests on 198 drivers involved in an accident. Presse Med 2000; 29(23): 1275-1278.
  24. Walsh JM, Crouch DJ, Danaceau JP, Cangianelli L, Liddicoat L, Adkins R. Evaluation of ten oral fluid point-of-collection drug-testing devices. J Anal Toxicol. 2007; 31(1): 44-54 [PubMed].
  25. Walsh JM, Flegel R, Crouch DJ, Cangianelli L, Baudys J. An evaluation of rapid point-of-collection oral fluid drug-testing devices. J Anal Toxicol. 2003; 27(7): 429-439 [PubMed].
  26. Pehrsson A, Gunnar T, Engblom C, Seppa H, Jama A, Lillsunde P. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Forensic Sci Int. 2008; 175(2-3): 140-148 [CrossRef] [PubMed].
  27. Walsh JM. New technology and new initiatives in U.S. workplace testing. Forensic Sci Int. 2008; 174(2-3): 120-124 [CrossRef] [PubMed].
  28. Bush DM. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. Forensic Sci Int. 2008; 174(2-3): 111-119 [CrossRef] [PubMed].
  29. Standards Australia. Australian Standard. Procedures for specimen collection and the detection and quantitation of drugs in oral fluid. Standards Australia, Sydney. 2006: 1-34.
  30. Cone EJ et coll. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J Anal Toxicol. 2002; 26(8): 541-546 [PubMed].